Here are six things to know:
1. This multicenter, prospective, observational, post-market study aims to further demonstrate the safety and effectiveness of the ProxiFuse system.
2. The system is designed for the fixation of osteotomies and reconstruction of the lesser toes following correction procedures for hammertoe, claw toe and mallet toe.
3. The first study patient was successfully treated by John Maskill, MD, at the Metro Health/OAM Surgery Center in Grand Rapids, Mich.
4. Dr. Maskill is an orthopedic surgeon practicing at Orthopaedic Associates of Michigan in Grand Rapids.
5. The study will enroll a minimum of 70 patients at six sites throughout the United States.
6. Outcomes will be collected and measured using the National Institutes of Health Patient Reported Outcome Measurement Information System.
More articles on devices:
7 notes on scoliosis braces molding to children’s movements
Hip fracture patients suffer worse outcomes than hip replacement patients — 4 facts
Precision Spine’s pedicle screw systems receive FDA approval: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
